eF-site ID 5gwi-ABCDEF
PDB Code 5gwi
Chain A, B, C, D, E, F

click to enlarge
Title Structure of a Human topoisomerase IIbeta fragment in complex with DNA and E7873R
Classification ISOMERASE/DNA/ISOMERASE INHIBITOR
Compound DNA topoisomerase 2-beta
Source Homo sapiens (Human) (5GWI)
Sequence A:  KGIPKLDDANDAGGKHSLECTLILTEGDSAKSLAVSGLGV
IGRDRYGVFPLRGKILNVREASHKQIMENAEINNIIKIVG
LQYKKSYDDAESLKTLRYGKIMIMTDQDQDGSHIKGLLIN
FIHHNWPSLLKHGFLEEFITKEAKEYFADMERHRILFRYA
GPEDDAAITLAFSKKKIDDRKEWLTNFMEDRRQRRLHGLK
HLTYNDFINKELILFSNSDNERSIPSLVDGFKPGQRKVLF
TCFKRNDKREVKVAQLAGSVAEMSAYHHGEQALMMTIVNL
AQNFVGSNNINLLQPIGQFGTRLHGGKDAASPRYIFTMLS
TLARLLFPAVDDNLLKFLYDDNQRVEPEWYIPIIPMVLIN
GAEGIGTGWACKLPNYDAREIVNNVRRMLDGLDPHPMLPN
YKNFKGTIQELGQNQYAVSGEIFVVDRNTVEITELPVRTW
TQVYKEQVLEPMLNGTDKTPALISDYKEYHTDTTVKFVVK
MTEEKLAQAEAAGLHKVFKLQTTLTCNSMVLFDHMGCLKK
YETVQDILKEFFDLRLSYYGLRKEWLVGMLGAESTKLNNQ
ARFILEKIQGKITIENRSKKDLIQMLVQRGYESDPVKAWK
EAQEGPDFNYILNMSLWSLTKEKVEELIKQRDAKGREVND
LKRKSPSDLWKEDLAAFVEELDKVESQERED
B:  SKIKGIPKLDDANDAGGKHSLECTLILTEGDSAKSLAVSG
LGVIGRDRYGVFPLRGKILNVREASHKQIMENAEINNIIK
IVGLQYKKSYDDAESLKTLRYGKIMIMTDQDQDGSHIKGL
LINFIHHNWPSLLKHGFLEEFITPAKEAKEYFADMERHRI
LFRYAGPEDDAAITLAFSKKKIDDRKEWLTNFMEDRRQRR
LHGTKHLTYNDFINKELILFSNSDNERSIPSLVDGFKPGQ
RKVLFTCFKRNDKREVKVAQLAGSVAEMSAYHHGEQALMM
TIVNLAQNFVGSNNINLLQPIGQFGTRLHGGKDAASPRYI
FTMLSTLARLLFPAVDDNLLKFLYDDNQRVEPEWYIPIIP
MVLINGAEGIGTGWACKLPNYDAREIVNNVRRMLDGLDPH
PMLPNYKNFKGTIQELGQNQYAVSGEIFVVDRNTVEITEL
PVRTWTQVYKEQVLEPMLNGPALISDYKEYHTDTTVKFVV
KMTEEKLAQAEAAGLHKVFKLQTTLTCNSMVLFDHMGCLK
KYETVQDILKEFFDLRLSYYGLRKEWLVGMLGAESTKLNN
QARFILEKIQGKITIENRSKKDLIQMLVQRGYESDPVKAW
KEAQGPDFNYILNMSLWSLTKEKVEELIKQRDAKGREVND
LKRKSPSDLWKEDLAAFVEELDKVESQERED
C:  AGCCGAGC
D:  TGCAGCTCGGCT
E:  AGCCGAGC
F:  TGCAGCTCGGCT
Description


Functional site

1) chain A
residue 478
type
sequence G
description binding site for residue N2R A 1301
source : AC1

2) chain A
residue 479
type
sequence D
description binding site for residue N2R A 1301
source : AC1

3) chain A
residue 502
type
sequence L
description binding site for residue N2R A 1301
source : AC1

4) chain A
residue 503
type
sequence R
description binding site for residue N2R A 1301
source : AC1

5) chain A
residue 778
type
sequence Q
description binding site for residue N2R A 1301
source : AC1

6) chain A
residue 782
type
sequence M
description binding site for residue N2R A 1301
source : AC1

7) chain C
residue 8
type
sequence C
description binding site for residue N2R A 1301
source : AC1

8) chain D
residue 9
type
sequence T
description binding site for residue N2R A 1301
source : AC1

9) chain D
residue 10
type
sequence G
description binding site for residue N2R A 1301
source : AC1

10) chain F
residue 12
type
sequence A
description binding site for residue N2R A 1301
source : AC1

11) chain F
residue 13
type
sequence G
description binding site for residue N2R A 1301
source : AC1

12) chain A
residue 478
type
sequence G
description binding site for residue N2N A 1302
source : AC2

13) chain A
residue 479
type
sequence D
description binding site for residue N2N A 1302
source : AC2

14) chain A
residue 502
type
sequence L
description binding site for residue N2N A 1302
source : AC2

15) chain A
residue 503
type
sequence R
description binding site for residue N2N A 1302
source : AC2

16) chain A
residue 778
type
sequence Q
description binding site for residue N2N A 1302
source : AC2

17) chain A
residue 782
type
sequence M
description binding site for residue N2N A 1302
source : AC2

18) chain C
residue 8
type
sequence C
description binding site for residue N2N A 1302
source : AC2

19) chain D
residue 9
type
sequence T
description binding site for residue N2N A 1302
source : AC2

20) chain D
residue 10
type
sequence G
description binding site for residue N2N A 1302
source : AC2

21) chain F
residue 12
type
sequence A
description binding site for residue N2N A 1302
source : AC2

22) chain F
residue 13
type
sequence G
description binding site for residue N2N A 1302
source : AC2

23) chain A
residue 557
type
sequence D
description binding site for residue MG A 1303
source : AC3

24) chain A
residue 559
type
sequence D
description binding site for residue MG A 1303
source : AC3

25) chain A
residue 867
type
sequence N
description binding site for residue MG A 1304
source : AC4

26) chain A
residue 868
type
sequence G
description binding site for residue MG A 1304
source : AC4

27) chain B
residue 478
type
sequence G
description binding site for residue N2R B 1301
source : AC5

28) chain B
residue 479
type
sequence D
description binding site for residue N2R B 1301
source : AC5

29) chain B
residue 503
type
sequence R
description binding site for residue N2R B 1301
source : AC5

30) chain B
residue 778
type
sequence Q
description binding site for residue N2R B 1301
source : AC5

31) chain B
residue 782
type
sequence M
description binding site for residue N2R B 1301
source : AC5

32) chain D
residue 12
type
sequence A
description binding site for residue N2R B 1301
source : AC5

33) chain D
residue 13
type
sequence G
description binding site for residue N2R B 1301
source : AC5

34) chain E
residue 8
type
sequence C
description binding site for residue N2R B 1301
source : AC5

35) chain F
residue 9
type
sequence T
description binding site for residue N2R B 1301
source : AC5

36) chain F
residue 10
type
sequence G
description binding site for residue N2R B 1301
source : AC5

37) chain B
residue 557
type
sequence D
description binding site for residue MG B 1303
source : AC6

38) chain B
residue 559
type
sequence D
description binding site for residue MG B 1303
source : AC6

39) chain B
residue 478
type
sequence G
description binding site for residue N2N B 1302
source : AC7

40) chain B
residue 479
type
sequence D
description binding site for residue N2N B 1302
source : AC7

41) chain B
residue 503
type
sequence R
description binding site for residue N2N B 1302
source : AC7

42) chain B
residue 778
type
sequence Q
description binding site for residue N2N B 1302
source : AC7

43) chain B
residue 781
type
sequence M
description binding site for residue N2N B 1302
source : AC7

44) chain B
residue 782
type
sequence M
description binding site for residue N2N B 1302
source : AC7

45) chain D
residue 12
type
sequence A
description binding site for residue N2N B 1302
source : AC7

46) chain D
residue 13
type
sequence G
description binding site for residue N2N B 1302
source : AC7

47) chain E
residue 8
type
sequence C
description binding site for residue N2N B 1302
source : AC7

48) chain F
residue 9
type
sequence T
description binding site for residue N2N B 1302
source : AC7

49) chain F
residue 10
type
sequence G
description binding site for residue N2N B 1302
source : AC7

50) chain E
residue 5
type
sequence G
description binding site for residue MG E 101
source : AC9

51) chain B
residue 641
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

52) chain B
residue 671
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

53) chain B
residue 707
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

54) chain B
residue 1087
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

55) chain A
residue 641
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

56) chain A
residue 671
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

57) chain A
residue 707
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

58) chain A
residue 1087
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI8

59) chain A
residue 638
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:25772364, ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI9

60) chain B
residue 638
type CROSSLNK
sequence K
description Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2) => ECO:0007744|PubMed:25772364, ECO:0007744|PubMed:28112733
source Swiss-Prot : SWS_FT_FI9

61) chain A
residue 821
type ACT_SITE
sequence Y
description O-(5'-phospho-DNA)-tyrosine intermediate => ECO:0000255|PROSITE-ProRule:PRU01384, ECO:0000269|PubMed:21778401
source Swiss-Prot : SWS_FT_FI1

62) chain B
residue 821
type ACT_SITE
sequence Y
description O-(5'-phospho-DNA)-tyrosine intermediate => ECO:0000255|PROSITE-ProRule:PRU01384, ECO:0000269|PubMed:21778401
source Swiss-Prot : SWS_FT_FI1

63) chain A
residue 505
type SITE
sequence K
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

64) chain B
residue 678
type SITE
sequence K
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

65) chain B
residue 739
type SITE
sequence K
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

66) chain B
residue 947
type SITE
sequence W
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

67) chain A
residue 508
type SITE
sequence N
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

68) chain A
residue 677
type SITE
sequence R
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

69) chain A
residue 678
type SITE
sequence K
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

70) chain A
residue 739
type SITE
sequence K
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

71) chain A
residue 947
type SITE
sequence W
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

72) chain B
residue 505
type SITE
sequence K
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

73) chain B
residue 508
type SITE
sequence N
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

74) chain B
residue 677
type SITE
sequence R
description Interaction with DNA
source Swiss-Prot : SWS_FT_FI4

75) chain A
residue 773
type SITE
sequence Y
description Interaction with DNA => ECO:0000255|PROSITE-ProRule:PRU00995
source Swiss-Prot : SWS_FT_FI5

76) chain B
residue 773
type SITE
sequence Y
description Interaction with DNA => ECO:0000255|PROSITE-ProRule:PRU00995
source Swiss-Prot : SWS_FT_FI5

77) chain A
residue 820
type SITE
sequence R
description Transition state stabilizer
source Swiss-Prot : SWS_FT_FI6

78) chain B
residue 820
type SITE
sequence R
description Transition state stabilizer
source Swiss-Prot : SWS_FT_FI6

79) chain A
residue 872
type SITE
sequence I
description Important for DNA bending; intercalates between base pairs of target DNA
source Swiss-Prot : SWS_FT_FI7

80) chain B
residue 872
type SITE
sequence I
description Important for DNA bending; intercalates between base pairs of target DNA
source Swiss-Prot : SWS_FT_FI7

81) chain A
residue 477
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00995
source Swiss-Prot : SWS_FT_FI2

82) chain B
residue 477
type BINDING
sequence E
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00995
source Swiss-Prot : SWS_FT_FI2

83) chain A
residue 557
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00995, ECO:0000269|PubMed:21778401
source Swiss-Prot : SWS_FT_FI3

84) chain A
residue 559
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00995, ECO:0000269|PubMed:21778401
source Swiss-Prot : SWS_FT_FI3

85) chain B
residue 557
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00995, ECO:0000269|PubMed:21778401
source Swiss-Prot : SWS_FT_FI3

86) chain B
residue 559
type BINDING
sequence D
description BINDING => ECO:0000255|PROSITE-ProRule:PRU00995, ECO:0000269|PubMed:21778401
source Swiss-Prot : SWS_FT_FI3

87) chain A
residue 475-483
type prosite
sequence LTEGDSAKS
description TOPOISOMERASE_II DNA topoisomerase II signature. LTEGDSAKS
source prosite : PS00177


Display surface

Download
Links